Bank of Montreal
INMB icon

Bank of Montreal’s INmune Bio INMB Stock Holding History

Bank of Montreal’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,987
Closed -$40.5K – 3879
2025
Q4 		$40.5K Buy
+25,987
New +$46.4K ﹤0.01% 3225
2021
Q2 		– Sell
-47,076
Closed -$536K – 4262
2021
Q1 		$536K Sell
47,076
-13,682
-23% -$246K ﹤0.01% 2600
2020
Q4 		$1.32M Sell
60,758
-463
-0.8% -$4.36K ﹤0.01% 2055
2020
Q3 		$651K Buy
+61,221
New +$623K ﹤0.01% 2196

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of Montreal's INMB Position: Q1 2026 in Review

Bank of Montreal sold out of INmune Bio (INMB) in Q1 2026, closing a stake of 25,987 shares — an estimated $40.5K sold.

Bank of Montreal first reported a position in INMB in Q3 2020 and held it in 4 quarters. The position peaked at $1.32M in Q4 2020. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • Bank of Montreal reported no remaining INmune Bio position as of Q1 2026 after selling out during the quarter.
  • Bank of Montreal sold 25,987 INmune Bio shares in Q1 2026, an estimated $40.5K.
  • Bank of Montreal first reported a position in INmune Bio in Q3 2020 and held it in 4 quarters.
  • Bank of Montreal's INmune Bio position peaked at $1.32M in Q4 2020.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.